KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Inventory (2016 - 2026)

Gilead Sciences filings provide 17 years of Inventory readings, the most recent being $1.8 billion for Q4 2025.

  • On a quarterly basis, Inventory rose 3.74% to $1.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 billion, a 3.74% increase, with the full-year FY2025 number at $1.8 billion, up 3.74% from a year prior.
  • Inventory hit $1.8 billion in Q4 2025 for Gilead Sciences, down from $1.8 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $2.0 billion in Q2 2024 to a low of $1.5 billion in Q3 2022.
  • Median Inventory over the past 5 years was $1.7 billion (2024), compared with a mean of $1.7 billion.
  • Biggest five-year swings in Inventory: surged 80.43% in 2021 and later fell 16.69% in 2022.
  • Gilead Sciences' Inventory stood at $1.6 billion in 2021, then dropped by 6.86% to $1.5 billion in 2022, then increased by 18.58% to $1.8 billion in 2023, then fell by 4.31% to $1.7 billion in 2024, then increased by 3.74% to $1.8 billion in 2025.
  • The last three reported values for Inventory were $1.8 billion (Q4 2025), $1.8 billion (Q3 2025), and $1.8 billion (Q2 2025) per Business Quant data.